All news

BioLife Solutions Received Notice of Delisting

Alpha Vantage · TradingView · · AI-summarised by FinFlash

BioLife Solutions (BLFS) received a notice of delisting from Nasdaq. This action followed the completion of its merger with Repligen, which led the company to cease meeting Nasdaq listing requirements. Trading of BLFS stock was halted after-market on October 5, 2026, and suspended as of the close on October 6, 2026, with plans to officially delist and terminate reporting obligations by filing Forms 25 and 15.

Read original source

BLFS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.